News

A new synthetic system may allow the programming of cell phones and other microelectronic devices to identify and treat disease.
Read Article

Johns Hopkins researchers have discovered a peptide that doubles the effect time of the Wet AMD drug. The new discovery will increase the quality of life for patients by reducing the number of required injections.
Read Article

NIH funds research of disinfecting robot that uses ultraviolet light to kill robots drug-resistant organisms. The funded research team is working to determine whether these robots can reduce the number of infectious diseases in hospitals.
Read Article

A new catalyst may be the key to advancement in the field of oligosaccharide synthesis.
Read Article

Ovid Therapeutics Inc., a New York biotech startup that develops drugs that treat rare neurological disorders are each caused by distinct genetic mutations in the brain, will open an office in Cambridge in collaboration with Takeda Pharmaceutical Co.
Read Article

 


Jobs

Software Developer – Scilligence, Cambridge, MA
Job Site

Scientist I, Research Technology, Cellular Model Development – Biogen, Cambridge, MA
Job Site

Research Scientist I – Diabetes
– Broad Institute, Boston, MA
Job Site

Scientist II – Shipp Lab
– Dana-Farber Cancer Institute, Boston, MA
Job Site

Genetic Biostatistician/Epidemiologist
– Mass. Eye and Ear Infirmary, Boston, MA
Job Site

Go Back